dr. grothey on treatment landscape of mcrc
Published 7 years ago • 218 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:35
dr. eng on the treatment landscape in metastatic colorectal cancer
-
1:27
dr. axel grothey on differences between correct and concur studies in mcrc
-
0:57
dr. grothey on biomarkers to inform metastatic crc treatment decisions
-
1:35
dr. axel grothey on bevacizumab beyond progression in metastatic colorectal cancer
-
3:04
treatment goals in refractory mcrc
-
18:11
treatments for colorectal cancer
-
4:08
meet alexia: stage iv colon cancer survivor
-
22:50
update: left versus right sided colon cancers: biomarkers versus biology
-
1:47
dr. axel grothey on the time course of regorafenib-associated adverse events
-
1:27
dr. grothey on fda approval of pembrolizumab in msi-high crc
-
2:04
dr. grothey on left- versus right-sided tumors in crc
-
11:50
colon cancer management - dr. axel grothey, part 1
-
3:21
newly diagnosed mcrc treatment goals
-
6:17
colorectal cancer & ctdna updates with dr. axel grothey
-
2:03
dr. axel grothey on the side effect profile of regorafenib in metastatic colorectal cancer
-
1:53
the role of sidedness in colorectal cancer
-
2:04
dr. lenz on the changing landscape of metastatic colorectal cancer
-
1:55
dr. grothey describes the phase iii correct study
-
1:43
axel grothey, md | what is signatera?
-
1:48
dr. grothey discusses novel agents for colorectal cancer
-
2:37
meet dr. axel grothey
-
7:32
treatment options in refractory mcrc